EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for IFRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Liminatus Pharma, Inc. -0.0312
Oruka Therapeutics, Inc. -0.5767
MapLight Therapeutics, Inc. -1.342
Kailera Therapeutics, Inc. --
QIAGEN NV 0.3257

EPS Diluted (Quarterly) Related Metrics